{"entity":{"type":"insider","cik":"0001648096","url":"/insider/0001648096","json_url":"/insider/0001648096.json","name":"Pinion John Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2019-04-17","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Pinion John Richard","source":"filing","n_filings":12,"first_seen":"2019-04-17","last_seen":"2026-03-03"}],"transactions":[{"id":5762435,"accession":"0001193125-26-089287","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-089287","line_url":"/filing/0001193125-26-089287#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10029.0,"shares_display":"10,029","price_per_share":22.8,"price_display":"22.80","price_state":"stated","total_value":228661.2,"total_display":"228,661.20","total_whole":"228,661","shares_owned_after":110026.0,"shares_owned_after_display":"110,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":4834702,"accession":"0000950170-25-032785","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-032785","line_url":"/filing/0000950170-25-032785#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14439.0,"shares_display":"14,439","price_per_share":42.1,"price_display":"42.10","price_state":"stated","total_value":607881.9,"total_display":"607,881.90","total_whole":"607,882","shares_owned_after":107766.0,"shares_owned_after_display":"107,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2586948,"accession":"0000950170-24-026648","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-026648","line_url":"/filing/0000950170-24-026648#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4173.0,"shares_display":"4,173","price_per_share":53.76,"price_display":"53.76","price_state":"stated","total_value":224340.48,"total_display":"224,340.48","total_whole":"224,340","shares_owned_after":89268.0,"shares_owned_after_display":"89,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":8077012,"accession":"0001209191-23-030931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030931","line_url":"/filing/0001209191-23-030931#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2012.0,"shares_display":"2,012","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":100600.0,"total_display":"100,600.00","total_whole":"100,600","shares_owned_after":74744.0,"shares_owned_after_display":"74,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":8019260,"accession":"0001209191-23-016042","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-016042","line_url":"/filing/0001209191-23-016042#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3755.0,"shares_display":"3,755","price_per_share":45.26,"price_display":"45.26","price_state":"stated","total_value":169951.3,"total_display":"169,951.30","total_whole":"169,951","shares_owned_after":80174.0,"shares_owned_after_display":"80,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":6424443,"accession":"0001209191-22-015823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015823","line_url":"/filing/0001209191-22-015823#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4498.0,"shares_display":"4,498","price_per_share":66.62,"price_display":"66.62","price_state":"stated","total_value":299656.76,"total_display":"299,656.76","total_whole":"299,657","shares_owned_after":45266.0,"shares_owned_after_display":"45,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":5480021,"accession":"0001209191-21-060748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060748","line_url":"/filing/0001209191-21-060748#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":81.14,"price_display":"81.14","price_state":"stated","total_value":29048.12,"total_display":"29,048.12","total_whole":"29,048","shares_owned_after":49764.0,"shares_owned_after_display":"49,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-18","scope":"insider"},{"id":4936744,"accession":"0001209191-21-031387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-031387","line_url":"/filing/0001209191-21-031387#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363.0,"shares_display":"363","price_per_share":113.69,"price_display":"113.69","price_state":"stated","total_value":41269.47,"total_display":"41,269.47","total_whole":"41,269","shares_owned_after":50122.0,"shares_owned_after_display":"50,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"},{"id":5093293,"accession":"0001209191-21-017561","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-017561","line_url":"/filing/0001209191-21-017561#line-3","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6198.0,"shares_display":"6,198","price_per_share":138.17,"price_display":"138.17","price_state":"stated","total_value":856377.66,"total_display":"856,377.66","total_whole":"856,378","shares_owned_after":50237.0,"shares_owned_after_display":"50,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2048993,"accession":"0001209191-20-055175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055175","line_url":"/filing/0001209191-20-055175#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":262.0,"shares_display":"262","price_per_share":88.0,"price_display":"88.00","price_state":"stated","total_value":23056.0,"total_display":"23,056.00","total_whole":"23,056","shares_owned_after":46299.0,"shares_owned_after_display":"46,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":2252003,"accession":"0001209191-20-054712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054712","line_url":"/filing/0001209191-20-054712#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2780.0,"shares_display":"2,780","price_per_share":94.47,"price_display":"94.47","price_state":"stated","total_value":262626.6,"total_display":"262,626.60","total_whole":"262,627","shares_owned_after":46561.0,"shares_owned_after_display":"46,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-13","scope":"insider"},{"id":9270855,"accession":"0001209191-19-025109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-025109","line_url":"/filing/0001209191-19-025109#line-1","is_derivative":false,"issuer_cik":"0001648096","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001648096","owner_cik":"0001648096","owner_name":"Pinion John Richard","owner_display_name":"Pinion John Richard","owner_url":"/insider/0001648096","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":722.0,"shares_display":"722","price_per_share":65.52,"price_display":"65.52","price_state":"stated","total_value":47305.44,"total_display":"47,305.44","total_whole":"47,305","shares_owned_after":36966.0,"shares_owned_after_display":"36,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-04-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Officer","n_filings":12,"first_seen":"2019-04-17","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001648096","retrieved_at":"2026-08-24T06:47:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}